Suppr超能文献

10. 心血管疾病与风险管理:2023 年糖尿病护理标准。

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.

出版信息

Diabetes Care. 2023 Jan 1;46(Suppl 1):S158-S190. doi: 10.2337/dc23-S010.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的“糖尿病护理标准”包括 ADA 当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA 专业实践委员会的成员是多学科专家委员会,负责每年更新护理标准,或根据需要更频繁地更新。有关 ADA 标准、声明和报告的详细描述,以及 ADA 临床实践建议的证据分级系统和专业实践委员会成员的完整列表,请参阅引言和方法。希望对护理标准发表意见的读者可在 professional.diabetes.org/SOC 上发表意见。

相似文献

1
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S158-S190. doi: 10.2337/dc23-S010.
2
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S179-S218. doi: 10.2337/dc24-S010.
3
7. Diabetes Technology: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
4
17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017.
5
6. Glycemic Targets: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
6
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
7
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S267-S278. doi: 10.2337/dc23-S016.
8
13. Older Adults: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S216-S229. doi: 10.2337/dc23-S013.
9
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S254-S266. doi: 10.2337/dc23-S015.
10
7. Diabetes Technology: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.

引用本文的文献

3
Consumption of Ultra-Processed Foods and Metabolic Parameters in Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Int J Environ Res Public Health. 2025 Aug 14;22(8):1275. doi: 10.3390/ijerph22081275.
7
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.
Diabetes Metab J. 2025 Jul;49(4):582-783. doi: 10.4093/dmj.2025.0469. Epub 2025 Jul 1.
8
Lipid Control in Patients With Type 2 Diabetes Mellitus: A Continuous Quality Improvement Study.
Cureus. 2025 Jun 3;17(6):e85278. doi: 10.7759/cureus.85278. eCollection 2025 Jun.
10
"Outcomes of treatment for people with type 2 diabetes within two nurse-led clinics in primary care in Iceland".
Int J Circumpolar Health. 2025 Dec;84(1):2517932. doi: 10.1080/22423982.2025.2517932. Epub 2025 Jun 11.

本文引用的文献

1
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials.
Lancet. 2022 Sep 3;400(10354):757-767. doi: 10.1016/S0140-6736(22)01429-5. Epub 2022 Aug 27.
2
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.
3
Treatment for Mild Chronic Hypertension during Pregnancy.
N Engl J Med. 2022 May 12;386(19):1781-1792. doi: 10.1056/NEJMoa2201295. Epub 2022 Apr 2.
4
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Nat Med. 2022 Mar;28(3):568-574. doi: 10.1038/s41591-021-01659-1. Epub 2022 Feb 28.
5
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.
Nat Med. 2022 Apr;28(4):809-813. doi: 10.1038/s41591-022-01703-8. Epub 2022 Feb 28.
7
9
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.
Nat Med. 2021 Nov;27(11):1954-1960. doi: 10.1038/s41591-021-01536-x. Epub 2021 Oct 28.
10
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
N Engl J Med. 2021 Sep 30;385(14):1268-1279. doi: 10.1056/NEJMoa2111437. Epub 2021 Aug 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验